Skip to main content
Clinical Trials/NCT06423989
NCT06423989RecruitingNot Applicable

Role of Immunoglobulin in Male Infertility

Dr Salma kafeel Qureshi2 sites in 1 country50 target enrollmentStarted: April 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
50
Locations
2
Primary Endpoint
Sperm morphology

Study Overview

Brief Summary

to investigate the role of IVIG in male infertility and to determine its benefits in term of semen parameters and assisted reproduction outcome

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • male patients

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Sperm morphology

Time Frame: 6 month

Percentage of normal sperm

Semen parameters percentage improvement

Time Frame: 6 month

Sperm concentration/ml

Sperm motility

Time Frame: 6 month

Percentage active motile sperm

Secondary Outcomes

  • Assisted Reproduction outcome measure(12 months)

Investigators

Sponsor
Dr Salma kafeel Qureshi
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Dr Salma kafeel Qureshi

Medical director head of Gynaecological and Reproductive unit

Salma Kafeel Medical Centre

Study Sites (2)

Loading locations...

Similar Trials